Biotherapeutics
Cell Line Market
Biotherapeutics Cell Line Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Biotherapeutics Cell Line Market Size and Growth
The global biotherapeutics cell line market is anticipated to witness significant growth due to the increasing demand for personalized medicine and advancements in biotechnology. The market size is projected to reach USD XX billion by 2025. Key factors driving market growth include the rising prevalence of chronic diseases and the need for more effective and targeted treatments. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Becton Dickinson
◍ Beckman Coulter
◍ Boehringer Ingelheim Pharma
◍ CMC Biologics
◍ Catalent
◍ Lonza Group
◍ ProBioGen
◍ Partec
◍ SAFC
◍ Sony Biotechnology
◍ Selexis
◍ Thermo Fisher Scientific
The Biotherapeutics Cell Line Market is highly competitive with key players including Becton Dickinson, Beckman Coulter, Boehringer Ingelheim Pharma, CMC Biologics, Catalent, Lonza Group, ProBioGen, Partec, SAFC, Sony Biotechnology, Selexis, and Thermo Fisher Scientific. These companies utilize biotherapeutics cell lines for drug development and production, contributing to the growth of the market.
- Becton Dickinson reported sales revenue of $17.1 billion in 2020.
- Lonza Group reported sales revenue of CHF 5.17 billion in 2020.
- Thermo Fisher Scientific reported sales revenue of $32.22 billion in 2020.
Request Sample Report
Market Segmentation
By Application
Cancer
Request Sample Report
By Product
Single Cell Cloning
Transfection and Selection
Market Growth
Request Sample Report
$ X Billion USD
